Search results
Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Yahoo News UK· 3 hours ago'Far more benefit than harm' It is widely accepted that the AZ vaccine - and other COVID jabs -...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 55 minutes agoNovavax struggled after its COVID-19 vaccine was delayed by manufacturing issues early in...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 4 days agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
National Academies Report: COVID-19 Vaccines Don’t Cause Many Potential Harms
Journal of the American Medical Association· 16 hours agoThe COVID-19 vaccines made by Pfizer-BioNTech and Moderna do not cause such conditions as female infertility, myocardial infarction, ...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 7 hours agoUnder the terms of the agreement, Sanofi will begin to book sales of Novavax’s COVID-19 vaccine...
AstraZeneca pulls its COVID-19 vaccine from Europe
Boston Herald· 1 day agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 4 days agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...
Being vaccinated against COVID-19 reduces the severity of the illness
Digital Journal· 1 day agoA new study reveals how COVID-19 vaccines prevent severe disease. This is based on research...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
What's Going With BioNTech Stock On Monday?
Benzinga· 4 days agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...